Development and Validation of an RNA Binding Protein-associated Prognostic Model for Hepatocellular Carcinoma
Open Access
- 13 April 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2020.00103
Abstract
The survival rate of patients with hepatocellular carcinoma is variable. The abnormal expression of RNA-binding proteins (RBPs) is closely related to the occurrence and development of malignant tumors. The primary aim of this study was to identify RBPs related to the prognosis of liver cancer and to construct a prognostic model of liver cancer.Keywords
This publication has 15 references indexed in Scilit:
- Hepatocellular CarcinomaThe New England Journal of Medicine, 2019
- miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KITCell Communication and Signaling, 2018
- Liver cancer incidence and mortality in China: Temporal trends and projections to 2030Chinese Journal of Cancer Research, 2018
- Comprehensive Genomic Characterization of RNA-Binding Proteins across Human CancersCell Reports, 2018
- Systemic Therapy for Hepatocellular Carcinoma: 2017 UpdateOncology, 2017
- Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular CarcinomaCancer Cell, 2017
- IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancerGenes & Development, 2016
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Principles and Properties of Eukaryotic mRNPsMolecular Cell, 2014